Skip to main content

Table 3 Main * diagnoses of the 1449 events reported in HIV-infected adults receiving antiretroviral treatment, IeDEA West Africa, December 2009 to December 2011

From: Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration

Diagnosis classification, number (%) Total 1449 Aconda-CePReF CMSDS CTA/CNHU
N = 1449 n = 955 n = 239 n = 255
AIDS-defining events         
   WHO stage 4 events 137 (9.5) 68 (7.1) 31 (13) 38 (14.9)
   WHO stage 3 events 338 (23.3) 214 (22.4) 24 (10) 100 (39.2)
   WHO stage 2 events 6 (0.4) 5 (0.5) 0 (0) 1 (0,4)
Non-AIDS-defining events         
   Non AIDS classifying infections 472 (32.6) 379 (39.7) 51 (21.3) 42 (16.5)
   Side effects** 104 (7.2) 34 (3.6) 32 (13.4) 38 (14.9)
   Other diagnosed diseases 63 (4.3) 35 (3.7) 12 (5) 16 (6.3)
Syndromic diagnoses*** 228 (16.0) 160 (17.0) 55 (23.0) 13 (5.1))
Death 101 (7.0) 60 (6.0) 34 (14.2) 7 (3.0)
  1. *: one diagnosis per event.
  2. **: (anemia = 36, peripheral neuropathy = 33, toxiderma = 21, neutropenia = 5, lipodystrophy = 4, acute delusional psychosis = 2, hyperlactatemia = 2, hepatitis = 1).
  3. ***[anemia = 72, fever = 46, general signs (Asthenia, anorexia = 37), digestive signs (diarrhea, vomiting) = 30, other signs = 43].